cabozantinib
exelixis
['atlantis', 'bladder', 'cabozantinib']
rob jones : targeted therapy (cabozantinib) without immunotherapy didn t show significant benefit compared to placebo as maintenance therapy in people with metastatic #bladdercancer who had responded to platinum-based chemotherapy. #asco22 atlantis 
she/her. CEO of @BladderCancerUK. President of @WorldBladderCan. Board member at @EauPatient. ??????????????????????????